We have shown that metformin, as well as the PPARγ agonist rosiglitazone, accelerate the resolution of pulmonary fibrosis at least partly via inducing the transdifferentiation of collagen-secreting myofibroblasts into pro-alveologenic lipofibroblasts [17,18]. Here, PPARG is linked to pulmonary fibrosis.